TriSalus Life Sciences, Inc.

MedTech Acquisition Corp, trading under the ticker MTAC, is a blank-check company that filed an 8-K with the SEC on December 23, 2020, during the early stages of its life as a publicly listed SPAC. Focused on the healthcare and life sciences sector, MTAC completed its IPO in 2020 and was targeting merger opportunities in medical technology and related therapeutic areas. The company is associated with TriSalus Life Sciences, a medical device firm developing targeted drug delivery solutions for liver and pancreatic cancers. The December 2020 8-K filing reflects a material event disclosure consistent with SPAC reporting obligations during the search phase. Sign up on SpacDesk for full filing history, deal timeline, and sponsor data on MTAC and hundreds of other SPACs.